Saima Shahid, MD | |
3500 University Blvd, Ames, IA 50010-8676 | |
(515) 239-3100 | |
(515) 239-3045 |
Full Name | Saima Shahid |
---|---|
Gender | Female |
Speciality | Family Practice |
Experience | 34 Years |
Location | 3500 University Blvd, Ames, Iowa |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1306852967 | NPI | - | NPPES |
1306852967 | Medicaid | IA | |
1212332 | Medicaid | IA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Q00000X | Family Medicine | 33605 (Iowa) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Mary Greeley Medical Center | Ames, IA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Mcfarland Clinic Pc | 1254244239 | 320 |
News Archive
RetroVirox, Inc., a biotechnology company specializing in the development of novel antivirals, announced today that it has received a grant award of $296,875 from the National Institute of Allergy and Infectious Disease (NIAID), of the National Institutes of Health (NIH). This is the second award to RetroVirox from the NIH in less than six months. In March 2009 the company received its first grant to develop novel inhibitors of HIV entry.
Soligenix, Inc., a clinical stage biopharmaceutical company focused on developing products to treat serious inflammatory diseases where there remains an unmet medical need, as well as developing several biodefense vaccines and therapeutics, announced today that it has initiated a Phase 2, randomized, double-blind, placebo-controlled study evaluating SGX942, a first-in-class innate defense regulator, as a treatment for oral mucositis in patients undergoing chemoradiation therapy for head and neck cancer.
The state's legislature adjourned without a budget because of arguments over growing the program for low income residents, and lawmakers will come back to try again March 24.
Scientists at the Centro Nacional de Investigaciones Cardiovasculares and the Instituto de Investigación Sanitaria-Fundación Jiménez Díaz in Madrid have demonstrated that a proteins present in early atheroma plaques-accumulations of cholesterol in the wall of arteries-could be used as a biomarker to detect atherosclerosis in the subclinical phase, before the appearance of symptoms.
› Verified 9 days ago
Entity Name | Mcfarland Clinic Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1639135643 PECOS PAC ID: 1254244239 Enrollment ID: O20031106000338 |
News Archive
RetroVirox, Inc., a biotechnology company specializing in the development of novel antivirals, announced today that it has received a grant award of $296,875 from the National Institute of Allergy and Infectious Disease (NIAID), of the National Institutes of Health (NIH). This is the second award to RetroVirox from the NIH in less than six months. In March 2009 the company received its first grant to develop novel inhibitors of HIV entry.
Soligenix, Inc., a clinical stage biopharmaceutical company focused on developing products to treat serious inflammatory diseases where there remains an unmet medical need, as well as developing several biodefense vaccines and therapeutics, announced today that it has initiated a Phase 2, randomized, double-blind, placebo-controlled study evaluating SGX942, a first-in-class innate defense regulator, as a treatment for oral mucositis in patients undergoing chemoradiation therapy for head and neck cancer.
The state's legislature adjourned without a budget because of arguments over growing the program for low income residents, and lawmakers will come back to try again March 24.
Scientists at the Centro Nacional de Investigaciones Cardiovasculares and the Instituto de Investigación Sanitaria-Fundación Jiménez Díaz in Madrid have demonstrated that a proteins present in early atheroma plaques-accumulations of cholesterol in the wall of arteries-could be used as a biomarker to detect atherosclerosis in the subclinical phase, before the appearance of symptoms.
› Verified 9 days ago
Mailing Address | Practice Location Address |
---|---|
Saima Shahid, MD 1215 Duff Ave, Ames, IA 50010-5469 Ph: (515) 239-4400 | Saima Shahid, MD 3500 University Blvd, Ames, IA 50010-8676 Ph: (515) 239-3100 |
News Archive
RetroVirox, Inc., a biotechnology company specializing in the development of novel antivirals, announced today that it has received a grant award of $296,875 from the National Institute of Allergy and Infectious Disease (NIAID), of the National Institutes of Health (NIH). This is the second award to RetroVirox from the NIH in less than six months. In March 2009 the company received its first grant to develop novel inhibitors of HIV entry.
Soligenix, Inc., a clinical stage biopharmaceutical company focused on developing products to treat serious inflammatory diseases where there remains an unmet medical need, as well as developing several biodefense vaccines and therapeutics, announced today that it has initiated a Phase 2, randomized, double-blind, placebo-controlled study evaluating SGX942, a first-in-class innate defense regulator, as a treatment for oral mucositis in patients undergoing chemoradiation therapy for head and neck cancer.
The state's legislature adjourned without a budget because of arguments over growing the program for low income residents, and lawmakers will come back to try again March 24.
Scientists at the Centro Nacional de Investigaciones Cardiovasculares and the Instituto de Investigación Sanitaria-Fundación Jiménez Díaz in Madrid have demonstrated that a proteins present in early atheroma plaques-accumulations of cholesterol in the wall of arteries-could be used as a biomarker to detect atherosclerosis in the subclinical phase, before the appearance of symptoms.
› Verified 9 days ago
James Bice, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: Isu Thielen Student Health Center, 2647 Union Drive, Ames, IA 50011 Phone: 515-294-5801 Fax: 515-294-5457 | |
Dr. Peter Quintin Wolfe, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 3600 West Lincolnway, Ames, IA 50010 Phone: 515-663-4892 Fax: 515-663-4899 | |
Rienera Suzanne Sivesind, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2724 Meadow Glen Rd, Ames, IA 50014 Phone: 360-452-7891 Fax: 360-452-8087 | |
Samuel Eliot Stanton, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 925 Gaskill Dr, Ames, IA 50014 Phone: 515-231-7309 Fax: 888-806-4041 | |
Paul W Baumert Jr., MD Family Medicine Medicare: May Accept Medicare Assignments Practice Location: 3500 University Blvd, Ames, IA 50010 Phone: 515-239-3040 | |
Elizabeth Mccurdy, DO Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 3510 Lincoln Way, Ames, IA 50014 Phone: 515-232-0628 Fax: 515-232-0727 | |
Dr. David Adam Carlyle, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2309 Buchanan Dr, Ames, IA 50010 Phone: 515-233-6988 |